套细胞淋巴瘤
慢性淋巴细胞白血病
免疫分型
细胞周期蛋白D1
脾边缘带淋巴瘤
淋巴瘤
淋巴细胞增多症
病理
癌症研究
氟达拉滨
医学
白血病
免疫学
化疗
B细胞
内科学
癌症
抗体
细胞周期
流式细胞术
环磷酰胺
作者
Yue Zhao,Jenna McCracken,Catherine Rehder,Endi Wang
标识
DOI:10.1016/j.clml.2021.10.017
摘要
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) occasionally undergoes Richter transformation, mostly to diffuse large B-cell lymphoma, but its evolution to other types of B-cell lymphoma is rare. We report a CLL evolved to mantle cell lymphoma by acquiring t(11;14)(q13;q32); CCND1-IGH.A Retrospective review of clinical and laboratory data.A 39-year-old male patient was diagnosed with CLL/SLL, and was initially followed without specific treatment, but subsequently received chlorambucil/fludarabine/rituximab due to exacerbated lymphocytosis. While his CLL/SLL waned and waxed, the immunophenotype and genotype of neoplastic B-cells remained unchanged, without cyclin D1 expression and CCND1-IGH fusion. Eleven years after the diagnosis, the patient's disease showed evidence of progression. Bone marrow examination demonstrated "CLL" with the morphology and immunophenotype similar to those seen in the previous biopsies. Unexpectedly, the neoplastic B-cells demonstrated cyclin D1 expression and harbored t(11;14)(q13;q32); CCND1-IGH, suggesting a clonal evolution to mantle cell lymphoma. He subsequently received cytoreductive chemotherapy followed by allogenic bone marrow transplant and remained in remission since then.The retention of immunophenotype suggests a clonal relationship between CLL/SLL and mantle cell lymphoma. While the acquisition of t(11;14)(q13;q32); CCND1-IGH likely alters the disease course, the pathogenesis of this illegitimate translocation in CLL remains to be studied.
科研通智能强力驱动
Strongly Powered by AbleSci AI